Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-05

FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (Radha Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved Radha Pharmaceuticals Inc's original ANDA for a generic carbidopa-levodopa product, used to treat Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

ORIG AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)